Simian Virus 40: The link with human malignant mesothelioma is well established

Anticancer Research

Volumn 20, Issue 2 A, 2000, Pages 875-877

  Carbone, Michele ^a   Rizzo, Paola ^a   Pass, Harvey ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Human malignant mesothelioma; Simian Virus 40

Indexed keywords

ASBESTOS;

ARTICLE; ENVIRONMENTAL FACTOR; MALIGNANT MESOTHELIOMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SIMIAN VIRUS 40; VIRUS CARCINOGENESIS;

ANIMALS; ASBESTOS; CRICETINAE; EUROPE; HEART NEOPLASMS; HUMANS; INCIDENCE; MESOTHELIOMA; PERICARDIUM; PERITONEAL NEOPLASMS; PLEURAL NEOPLASMS; SIMIAN VIRUS 40; UNITED STATES;

EID: 0034011844     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Carbone M, Rizzo P and Pass HI: Simian virus 40, poliovaccines and human tumors: A review of reccent developments. Oncogenc 15: 1877-1888, 1997.
2. Xu L, Flynn B, Ungar S, Pass HI, Linnainmaa K, Mattson K, and Gerwin B: Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen. Carcinogenesis 20: 773-783, 1994.
3. Carbone M, Fisher S, Powers A, Pass HI and Rizzo P: New molecular and epidemiological issues in mesothelioma: Role of SV40. J Cell Physiol, In Press.
4. Butel JS and Lednicky JA: Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 91: 119-134, 1999.
5. Lewis AM and Cook JL: Presence of allograft rejection resistance in simian virus 40 transformed hamster cells and its possible role in tumor development. Proc Natl Acad Sci USA. 77: 2886-2889, 1980.
6. Bryan TM and Reddel R: SV40 induced immortilazation of human cells. Critical Revs in Oncogenesis 5: 331-357, 1994.
7. Strickler HD, Goedert JJ, Fleming M, Travis WD, Williams AE, Rabkin CS, Daniel RW and Shah KV: Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers. Prey 5: 473-475, 1996.
8. Mulatero C, Surentheran T, Breuer J and Rudd RM: Simian virus 40 and human pleural mesothelioma. Thorax 54: 60-61, 1999.
9. Jasani B. Simian virus 40 and human pleural mesothelioma. Thorax, In Press.
10. Carbone M, Rizzo P, Procopio A, Giuliano M, Pass HI, Gebhardt MC, Mangham C, Hansen M, Malkin DF, Bushart G, Pompetti F, Picci P, Levine AS, Bergsagel JD, and Garcea RL: SV40-like sequences in human bone tumors. Oncogene 13: 527-535, 1996.
11. Hirvonen A, Mattson K, Karjalainen A, Ollikainen T, Tammilehto L, Hovi T, Vainio H, Pass HI, Di Resta I, Carbone M and Linnainmaa K: SV40-like sequences were not detectable in Finnish mesotheliomas not exposed to SV40-contaminated poliovaccines. Molecular Carcinogenesis, In Press.
12. Martini F, Iaccheri L, Lazzarin L, Carinci P, Corallini A, Gerosa M, Iuzzolino P, Barbanti-Brodano G and Tognon M: SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 56: 4820-4825, 1996.
13. Galateau-Salle F, Bidet P, Iwatsubo Y, Gennetay E, Renier A, Letorneux M, Pairon JC, Moritz S, Brochard P, Jaurand MC, and Freymuth F: SV40 like Dna in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases. J Pathol 184: 252-257, 1998.
14. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridar V, de Bartolomeis A, Esposito V, Giuliano MT, Steinberg SM, Levine AS, Giordano A and Pass HI: Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med. 3: 908-912, 1997.
15. De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass HI, Giordano GC, Baldi F, Carbone M and Giordano A: The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus 40 large T antigen in mesotheliomas. Nat Med 3: 913-916, 1997.
16. Rizzo P, Di RI, Powers A, Matker CM, Zhang A, Mutti L, Kast WM, Pass H and Carbone M: The detection of simian virus 40 in human tumors by polymerase chain reaction. Monaldi Arch Chest Dis 53: 202-210, 1948.
17. Bright RK, Shearer MH, Pass HI and Kennedy RC: Immunotherapy of SV40 induced tumours in mice: a model for vaccine development. Dev Biol Stand 94: 341-353, 1998.
18. Xie YC, Hwang C, Overwijk W, Zeng Z, Eng MH, Mule JJ, Imperiale MJ, Restifo NP and Sanda MG: Induction of tunlor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen. J Natl Cancer Inst 91: 169-175, 1999.